Epicyt Pharma Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 12

Epicyt Pharma General Information

Description

Developer of pharmaceutical drugs intended to focus on calcium absorption in the intestines and how it affects bone health. The company intends to develop drugs that improve bone health in patient groups with reduced calcium uptake in the stomach, enabling individuals to keep their bones healthy.

Contact Information

Website
www.epicyt.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Sörredsbacken 20
  • South East
  • 418 78 Gothenburg
  • Sweden
+46
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • Sörredsbacken 20
  • South East
  • 418 78 Gothenburg
  • Sweden
+46

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Epicyt Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC 01-May-2022 Completed Generating Revenue
To view Epicyt Pharma’s complete valuation and funding history, request access »

Epicyt Pharma Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • 7

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Epicyt Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3768274-A4 A composition for use in the treatment of conditions caused by calcium deficiency Active 19-Mar-2018
AU-2019239073-A1 A composition for use in the treatment of conditions caused by calcium deficiency Pending 19-Mar-2018
EP-3768274-A1 A composition for use in the treatment of conditions caused by calcium deficiency Active 19-Mar-2018
CA-3094162-A1 A composition for use in the treatment of conditions caused by calcium deficiency Pending 19-Mar-2018
US-20210000864-A1 A composition for use in the treatment of conditions caused by calcium deficiency Active 19-Mar-2018 A61K31/19
To view Epicyt Pharma’s complete patent history, request access »

Epicyt Pharma Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Albonja AB Other Minority
Almi Invest Venture Capital Minority
BENF AB Other Minority
Forsed Holding Holding Company Minority
Göran Lundegårdh Angel (individual) Minority
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

Epicyt Pharma FAQs

  • When was Epicyt Pharma founded?

    Epicyt Pharma was founded in 2007.

  • Where is Epicyt Pharma headquartered?

    Epicyt Pharma is headquartered in Gothenburg, Sweden.

  • What industry is Epicyt Pharma in?

    Epicyt Pharma’s primary industry is Drug Discovery.

  • Is Epicyt Pharma a private or public company?

    Epicyt Pharma is a Private company.

  • What is Epicyt Pharma’s current revenue?

    The current revenue for Epicyt Pharma is .

  • Who are Epicyt Pharma’s investors?

    Albonja AB, Almi Invest, BENF AB, Forsed Holding, and Göran Lundegårdh are 5 of 12 investors who have invested in Epicyt Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »